Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Emerging Animal & Zoonotic Disease Diagnostics Research

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Homeland Security → Sci Technology Acq DivisionView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Washington, DC, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Homeland Security → Sci Technology Acq Division
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Homeland Security → Sci Technology Acq Division
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Conduct research on emerging animal and zoonotic diseases, including pathogen detection, diagnostics development, outbreak modeling, and mitigation strategies.

Similar Contracts

Same NAICS industry code

NAICS: 541711
New
Federal
Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.
Aspr Administration For Strategic Preparedness And Response

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Grant
Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Federal
Infectious Disease Vaccine DevelopmentThe contract involves licensing the NanoFET platform to enable rapid-response vaccine development against viral and bacterial pathogens, leveraging its unique adjuvant-free immune activation and modular antigen integration capabilities. This technology allows for swift adaptation to emerging infectious threats by streamlining the design and production of vaccines without relying on traditional immune-stimulating additives, significantly reducing development timelines and enhancing safety profiles. The work is structured as a subcontract under the Department of Energy, with performance centered at Los Alamos, New Mexico, and is targeted toward advancing national defense and public health preparedness through next-generation vaccine platforms. The opportunity is open for proposals until December 18, 2026, and falls under NAICS code 541711, indicating it targets research and development in the physical, engineering, and life sciences. The contracting entity is Triad, the DOE Contractor, and the initiative aligns with broader federal efforts to build resilient, scalable biodefense capabilities. Participants must demonstrate technical proficiency in the NanoFET platform, experience in infectious disease vaccine design, and the capacity to execute rapid development cycles under strict timelines. Success in this effort will contribute directly to scalable, next-generation immunization technologies capable of addressing current and future biological threats.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details
NAICS: 541711
Federal
Modular Cancer Immunotherapy DevelopmentThe contract entails the license and development of the NanoFET platform for the creation of targeted cancer immunotherapies, leveraging its modular scaffold to deliver tumor-specific antigens and immune stimulators in a precise and effective manner. The work is focused on advancing next-generation immunotherapeutic approaches by engineering the platform to enhance immune recognition and response against cancer cells, with the goal of improving therapeutic outcomes and reducing off-target effects. The project requires collaboration to optimize the platform’s design, validate its efficacy in preclinical models, and prepare for subsequent clinical translation, all grounded in cutting-edge nanotechnology and immunological science. The contract is a subcontract under the Department of Energy, with performance centered in Los Alamos, New Mexico, 87545, and is classified under NAICS code 541711 for research and development in the physical, engineering, and life sciences. The solicitation was posted on June 17, 2026, with a response deadline of December 18, 2026, indicating a strategic timeline for proposal submission and evaluation. While details on set-aside status and point of contact are not provided, the project is positioned to align with national priorities in advanced biomedical innovation and cancer treatment, leveraging federal research infrastructure and expertise to drive transformative therapeutic solutions.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details

More opportunities from Department Of Homeland Security → Sci Technology Acq Division

Same awarding agency

NAICS: 541618
New
Federal
Quality Management System (QMS) Advisory & Gap Analysis SupportThe contract seeks to engage a provider for pre-audit advisory services aimed at preparing NUSTL for its ISO 9001:2015 recertification and surveillance audits. The scope includes conducting a comprehensive gap analysis to identify deficiencies in the current Quality Management System, reviewing and refining documented procedures and records, and delivering targeted staff training to ensure alignment with ISO 9001:2015 requirements. The services are designed to strengthen compliance, improve audit readiness, and ensure sustained quality performance across all relevant operational areas. The work must be completed in time to support the upcoming audit cycles, requiring timely and practical implementation guidance. This engagement is structured as a subcontract under the Department of Homeland Security’s Science and Technology Acquisition Division, classified under NAICS code 541618 for other scientific and technical consulting services. The opportunity was posted on July 24, 2026, with a response deadline of August 3, 2026, at 8:30 PM. While the exact place of performance and point of contact are not specified, the nature of the work implies a combination of on-site and remote support to assess internal processes and deliver training. The focus remains on delivering actionable, audit-ready improvements that sustain certification and enhance organizational efficiency under the ISO 9001:2015 framework.
Other Management Consulting Services

POSTED

5 days ago

DEADLINE

in 5 days
View Details
NAICS: 541620
Federal
Biosafety and Environmental Compliance (BSL-3)The contract titled Biosafety and Environmental Compliance (BSL-3) requires strict adherence to Biosafety Level 3 protocols, OSHA standards, ISO 14001 environmental management requirements, and all applicable federal environmental regulations during the decommissioning process. This subcontract, issued by the Department of Homeland Security’s Science and Technology Acquisition Division, mandates comprehensive safety and environmental controls to ensure the safe handling, decontamination, and disposal of hazardous materials associated with BSL-3 facilities. The work must be performed in full compliance with regulatory frameworks designed to protect personnel, the public, and the environment from biological and chemical hazards. The solicitation was posted on July 22, 2026, with a response deadline of August 22, 2026, and is classified under NAICS code 541620 for scientific research and development services. No set aside designation is specified, and the place of performance details are not provided, indicating the work may occur at any BSL-3 facility under the agency’s purview. The contractor is expected to demonstrate proven expertise in biosafety decommissioning, environmental compliance auditing, and regulatory documentation to meet federal obligations without disruption or risk of exposure. All activities must be conducted with precision and accountability, maintaining the highest standards of safety and environmental stewardship throughout the project lifecycle.
Environmental Consulting Services

POSTED

7 days ago

DEADLINE

in 24 days
View Details
NAICS: 221320
Federal
Wastewater Treatment System MaintenanceThe contract requires the operation and maintenance of wastewater treatment systems at the Pine Island Adult Detention Center to ensure continuous compliance with environmental regulations and uninterrupted service during the facility’s decommissioning phase. The work is classified under NAICS code 221320, indicating it falls within the wastewater treatment sector, and is structured as a subcontract under the Department of Homeland Security’s Science and Technology Acquisition Division. Performance is expected to occur at the PIADC location, with all activities centered on sustaining system functionality, proper treatment of sewage, and adherence to environmental standards throughout the transition period. The solicitation was posted on July 22, 2026, with a response deadline of August 22, 2026, providing potential offerors a one-month window to submit proposals. While the contract does not specify any set-aside preferences or detailed point of contact information, the emphasis is on reliable, compliant operation during a critical operational phase. The contractor must possess the technical expertise to handle complex wastewater systems under evolving regulatory demands and ensure no service interruptions occur during the decommissioning process, which may involve phased shutdowns, system modifications, or temporary adjustments to treatment protocols.
Sewage Treatment Facilities

POSTED

7 days ago

DEADLINE

in 24 days
View Details